BioForce Nanosciences says Nexus Capital Investments files initial beneficial ownership statement

• Nexus Capital Investments filed a Form 3 reporting a 10% ownership position in BioForce Nanosciences Holdings.
• Reported direct beneficial ownership of 26,700,000 shares of Common Stock, par value $0.001.
• Statement covered an event date of 04/22/2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioForce Nanosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001091818-26-000139), on September 04, 2026, and is solely responsible for the information contained therein.